THERMO FISHER SCIENTIFIC INC.Underwriting Agreement • August 17th, 2012 • Thermo Fisher Scientific Inc. • Measuring & controlling devices, nec • New York
Introductory. Thermo Fisher Scientific Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”), acting severally and not jointly, the respective amounts set forth in such Schedule A of $500,000,000 aggregate principal amount of the Company’s 1.850% Senior Notes due 2018 (the “2018 Notes”) and $800,000,000 aggregate principal amount of the Company’s 3.150% Senior Notes due 2023 (the “2023 Notes” and, together with the 2018 Notes, the “Notes”). Goldman, Sachs & Co., J.P. Morgan Securities LLC and RBS Securities Inc. have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Notes.
